BR112014002884A2 - composição para estimulação ovariana controlada - Google Patents

composição para estimulação ovariana controlada

Info

Publication number
BR112014002884A2
BR112014002884A2 BR112014002884A BR112014002884A BR112014002884A2 BR 112014002884 A2 BR112014002884 A2 BR 112014002884A2 BR 112014002884 A BR112014002884 A BR 112014002884A BR 112014002884 A BR112014002884 A BR 112014002884A BR 112014002884 A2 BR112014002884 A2 BR 112014002884A2
Authority
BR
Brazil
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
fsh
Prior art date
Application number
BR112014002884A
Other languages
English (en)
Inventor
Arce Joan-Carles
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014002884(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of BR112014002884A2 publication Critical patent/BR112014002884A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

resumo patente de invenção: "composição para estimulação ovariana controlada". a presente invenção refere-se a preparações incluindo fsh, por exemplo, fsh recombinante, para uso no tratamento de infertilidade.
BR112014002884A 2011-08-08 2012-08-08 composição para estimulação ovariana controlada BR112014002884A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08
PCT/EP2012/065507 WO2013020996A1 (en) 2011-08-08 2012-08-08 Composition for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
BR112014002884A2 true BR112014002884A2 (pt) 2017-02-21

Family

ID=46785372

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112014002884A BR112014002884A2 (pt) 2011-08-08 2012-08-08 composição para estimulação ovariana controlada
BR122020001644-2A BR122020001644B1 (pt) 2011-08-08 2012-08-08 Composição compreendendo hormônio folículo estimulante recombinante e uso do mesmo para o tratamento de infertilidade

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR122020001644-2A BR122020001644B1 (pt) 2011-08-08 2012-08-08 Composição compreendendo hormônio folículo estimulante recombinante e uso do mesmo para o tratamento de infertilidade

Country Status (31)

Country Link
US (4) US9694052B2 (pt)
EP (9) EP2821080B1 (pt)
JP (5) JP6161609B2 (pt)
KR (7) KR102499969B1 (pt)
CN (2) CN107281470A (pt)
AR (1) AR087476A1 (pt)
AU (3) AU2012293647B2 (pt)
BR (2) BR112014002884A2 (pt)
CA (1) CA2844282A1 (pt)
CY (1) CY1117214T1 (pt)
DK (8) DK3195875T3 (pt)
ES (8) ES2742163T3 (pt)
FI (2) FI4005588T3 (pt)
HK (2) HK1198005A1 (pt)
HR (8) HRP20240420T1 (pt)
HU (8) HUE053716T2 (pt)
IL (2) IL300380A (pt)
JO (1) JO3092B1 (pt)
LT (7) LT3395357T (pt)
MX (4) MX348981B (pt)
PL (8) PL3195875T3 (pt)
PT (6) PT3646881T (pt)
RS (8) RS64328B1 (pt)
RU (2) RU2739037C3 (pt)
SA (1) SA112330762B1 (pt)
SI (8) SI3756681T1 (pt)
SM (1) SMT201600038B (pt)
TR (2) TR201900071T4 (pt)
TW (2) TWI657822B (pt)
WO (1) WO2013020996A1 (pt)
ZA (2) ZA201400952B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
JP2018500934A (ja) * 2014-12-22 2018-01-18 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Cmp依存性シアリダーゼ活性
DK3283097T3 (da) * 2015-04-17 2020-04-20 Ferring Bv Fsh til behandling af infertilitet
WO2016207353A1 (en) 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation
CN113198005B (zh) * 2015-09-17 2024-09-06 广州汉腾生物科技有限公司 具有提高的稳定性的哺乳动物促卵泡激素组合物
TWI778979B (zh) * 2016-09-30 2022-10-01 瑞士商麥歐文科學有限公司 治療女性不孕症之方法
JOP20200034A1 (ar) 2017-09-01 2020-02-13 Ferring Bv تركيبة للتنشيط المتحكم فيه للمبيض
JP2021522268A (ja) 2018-04-30 2021-08-30 フェリング ベスローテン フェンノートシャップ 制御された卵巣刺激のための組成物
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗多囊卵巢综合征中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
AU2022451605A1 (en) 2022-04-01 2024-09-26 Ferring B.V. Mixed protocol for treatment of infertility
WO2023227761A1 (en) 2022-05-26 2023-11-30 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2024008971A1 (en) 2022-07-08 2024-01-11 Ferring B.V. Compositions and methods for intrauterine insemination (iui)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122732A0 (en) 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
CN1608078B (zh) * 2001-10-22 2012-07-25 默克雪兰诺有限公司 用于卵泡生成的促性腺激素
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
SI2621517T2 (sl) * 2010-09-29 2023-11-30 Ferring B.V. Sestavek za uporabo pri zdravljenju neplodnosti
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
MX2014001489A (es) 2014-04-25
PL3395357T3 (pl) 2019-11-29
SI3395357T1 (sl) 2019-09-30
MX2024008826A (es) 2024-07-25
TR201911269T4 (tr) 2019-08-21
HRP20210722T1 (hr) 2021-06-11
HUE054312T2 (hu) 2021-08-30
US20180028620A1 (en) 2018-02-01
SI2821080T1 (sl) 2019-01-31
EP3756681B1 (en) 2023-05-03
KR102111514B1 (ko) 2020-05-18
RS59107B1 (sr) 2019-09-30
FI4005588T3 (fi) 2024-05-15
AU2012293647B2 (en) 2016-10-06
RS61672B1 (sr) 2021-04-29
HUE040058T2 (hu) 2019-02-28
ES2742163T3 (es) 2020-02-13
EP3756681A1 (en) 2020-12-30
IL230696B1 (en) 2023-03-01
JP2019077693A (ja) 2019-05-23
PL4005588T3 (pl) 2024-06-10
PT2821080T (pt) 2018-12-17
ZA201506382B (en) 2017-01-25
EP3395357B1 (en) 2019-05-15
DK3566712T3 (da) 2021-04-19
ZA201400952B (en) 2022-03-30
RS58198B1 (sr) 2019-03-29
ES2977682T3 (es) 2024-08-28
TWI555530B (zh) 2016-11-01
ES2692774T3 (es) 2018-12-05
PL3566712T3 (pl) 2021-07-12
IL300380A (en) 2023-04-01
DK3395357T3 (da) 2019-08-19
DK3195875T3 (en) 2018-11-12
LT2821080T (lt) 2019-01-10
SI2741763T1 (sl) 2016-02-29
KR20230024442A (ko) 2023-02-20
PL3756681T3 (pl) 2023-08-21
LT3195875T (lt) 2018-11-12
HRP20240420T1 (hr) 2024-06-21
SI4005588T1 (sl) 2024-06-28
ES2562648T3 (es) 2016-03-07
MX2020010991A (es) 2020-11-09
HUE044610T2 (hu) 2019-11-28
NZ620369A (en) 2015-12-24
US20220370567A1 (en) 2022-11-24
JP2023134561A (ja) 2023-09-27
PT4005588T (pt) 2024-04-24
US11291708B2 (en) 2022-04-05
DK4005588T5 (da) 2024-08-05
KR102499969B1 (ko) 2023-02-14
RS61843B1 (sr) 2021-06-30
AU2016273925A1 (en) 2017-01-12
DK2821080T3 (en) 2019-01-28
LT3566712T (lt) 2021-03-10
IL230696A0 (en) 2014-03-31
HRP20160145T1 (hr) 2016-04-08
WO2013020996A1 (en) 2013-02-14
AU2012293647A1 (en) 2014-02-27
EP3646881A1 (en) 2020-05-06
PT3395357T (pt) 2019-08-27
LT3756681T (lt) 2023-07-25
LT3395357T (lt) 2019-08-26
PL3646881T3 (pl) 2021-11-02
FI3756681T3 (fi) 2023-07-28
CY1117214T1 (el) 2017-04-05
AU2018203222A1 (en) 2018-05-24
EP3195875B1 (en) 2018-07-25
RS54561B1 (en) 2016-06-30
PL2741763T3 (pl) 2016-07-29
MX2024008825A (es) 2024-07-25
SMT201600038B (it) 2016-02-25
KR20200121918A (ko) 2020-10-26
JP2014522871A (ja) 2014-09-08
KR20210099162A (ko) 2021-08-11
KR20190100449A (ko) 2019-08-28
US20140329748A1 (en) 2014-11-06
HUE053716T2 (hu) 2021-07-28
RU2613324C3 (ru) 2021-06-09
JP2017141253A (ja) 2017-08-17
US20200345814A1 (en) 2020-11-05
DK4005588T3 (da) 2024-04-29
HUE041769T2 (hu) 2019-05-28
ES2884947T3 (es) 2021-12-13
DK3756681T3 (da) 2023-07-31
KR102014469B1 (ko) 2019-08-26
EP3195875A1 (en) 2017-07-26
JP6161609B2 (ja) 2017-07-12
AR087476A1 (es) 2014-03-26
US9694052B2 (en) 2017-07-04
MX348981B (es) 2017-07-06
RU2739037C3 (ru) 2021-09-08
RU2613324C2 (ru) 2017-03-15
EP2821080A1 (en) 2015-01-07
KR20140054191A (ko) 2014-05-08
EP4005588B1 (en) 2024-02-07
JO3092B1 (ar) 2017-03-15
AU2018203222B2 (en) 2020-03-12
SA112330762B1 (ar) 2015-10-08
TW201309322A (zh) 2013-03-01
DK3646881T3 (da) 2021-07-26
TR201900071T4 (tr) 2019-01-21
PT3195875T (pt) 2018-10-31
LT4005588T (lt) 2024-03-25
SI3195875T1 (sl) 2018-11-30
TW201716082A (zh) 2017-05-16
EP3566712A1 (en) 2019-11-13
HUE066158T2 (hu) 2024-07-28
HRP20190023T1 (hr) 2019-02-22
HUE062640T2 (hu) 2023-11-28
RU2739037C2 (ru) 2020-12-21
SI3756681T1 (sl) 2023-08-31
CA2844282A1 (en) 2013-02-14
IL230696B2 (en) 2023-07-01
EP4306174A2 (en) 2024-01-17
RU2017106756A3 (pt) 2020-07-09
HK1204923A1 (en) 2015-12-11
EP4306174A3 (en) 2024-04-10
HRP20181639T1 (hr) 2018-12-14
TWI657822B (zh) 2019-05-01
JP6500050B2 (ja) 2019-04-10
PL2821080T3 (pl) 2019-04-30
ES2950911T3 (es) 2023-10-16
RS57897B1 (sr) 2019-01-31
AU2016273925B2 (en) 2018-03-15
EP2741763B1 (en) 2015-11-18
HUE027674T2 (en) 2016-11-28
EP3395357A1 (en) 2018-10-31
PT3646881T (pt) 2021-06-02
ES2704878T3 (es) 2019-03-20
CN103732243A (zh) 2014-04-16
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
RS64328B1 (sr) 2023-08-31
SI3566712T1 (sl) 2021-04-30
BR122020001644B1 (pt) 2022-08-02
RU2014102924A (ru) 2015-09-20
PT3756681T (pt) 2023-07-25
EP3646881B1 (en) 2021-04-28
EP4005588A1 (en) 2022-06-01
KR20210143934A (ko) 2021-11-29
JP2020147600A (ja) 2020-09-17
PL3195875T3 (pl) 2019-01-31
JP6718951B2 (ja) 2020-07-08
DK3756681T5 (da) 2024-08-26
JP7309660B2 (ja) 2023-07-18
HRP20210277T1 (hr) 2021-04-02
HK1198005A1 (zh) 2015-03-06
ES2871405T3 (es) 2021-10-28
SI3646881T1 (sl) 2021-08-31
KR20190140098A (ko) 2019-12-18
US10624953B2 (en) 2020-04-21
DK2741763T3 (da) 2016-02-15
HRP20230607T1 (hr) 2023-09-29
HRP20191437T1 (hr) 2019-11-15
LT3646881T (lt) 2021-05-25
KR102353144B1 (ko) 2022-01-18
CN107281470A (zh) 2017-10-24
EP3566712B1 (en) 2021-01-27
RU2017106756A (ru) 2019-01-23
RS65485B1 (sr) 2024-05-31

Similar Documents

Publication Publication Date Title
BR112014002884A2 (pt) composição para estimulação ovariana controlada
PH12019501393A1 (en) Afucosylated anti-fgfr2iiib antibodies
TN2014000134A1 (en) Therapeutic peptides
PH12015501392A1 (en) Pesticidal compositions and processes related thereto
BR112014011594A2 (pt) anticorpos anti-il-36r
MX346665B (es) Composiciones pesticidas y procedimientos relacionados con estas.
BR112015012987A2 (pt) composições compreendendo anticorpos anti-cd38 e lenalidomida
MX2015011075A (es) Peptidos terapeuticos.
MX371187B (es) Péptidos terapéuticos.
PH12014502397A1 (en) Pesticidal compositions and processes related thereto
PH12015501394A1 (en) Pesticidal compositions and processes related thereto
BR112015029686A2 (pt) composições para o tratamento de superfícies compreendendo corantes fotocrômicos
NZ761006A (en) Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
BR112014020826A2 (pt) moduladores e métodos de uso
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
IN2015DN03327A (pt)
BR112014004828A2 (pt) método para preparação de uma composição compreendendo anticorpos altamente concentrados por ultrafiltração
PH12014502406B1 (en) Anti-il-23p19 antibodies
BR112014009866A2 (pt) formulações de anticorpos e métodos
MX2014001766A (es) Anticuerpos de neuregulina y sus usos.
BR112015008824A2 (pt) linhagens melhoradas de microalgas e processo das mesmas
BR112016007816A2 (pt) composições peptídicas inovadoras
ES2426017A2 (es) Microemulsión que comprende colagenasa y usos
TN2014000207A1 (en) Anti il-36r antibodies

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]